Nafis A. Rahman
Turku, 20520, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
CD8+ T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cells.
Journal: Science advances
Published: May 21, 2025
CircSMEK1 Suppresses HCC via the hnRNPK-IGF2-AKT Axis: A Diagnostic Biomarker and Therapeutic Target.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2025
Targeted destruction of follicle stimulating hormone receptor-positive cancer cells in vitro and in vivo by a lytic peptide Phor21-FSHβ conjugate.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 19, 2025
Liquid-liquid phase separation of ATXN2L enhances mRNA translation in hepatocellular carcinoma.
Journal: Cell reports
Published: March 11, 2025
Comment on "Atlas of Fshr Expression From Novel Reporter Mice".
Journal: Endocrinology
Published: February 27, 2025
Hecate-FSHβ33-53C/S lytic peptide conjugate selectively kills targeted follicle stimulating hormone receptor (FSHR)-positive cancer cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 26, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.
Journal: Cancer communications (London, England)
Published: November 20, 2024
miR-423-3p inhibits CTNNBIP1/WNT preventing hyperandrogenic polycystic ovary syndrome†.
Journal: Biology of reproduction
Published: October 23, 2024
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma.
Journal: bioRxiv : the preprint server for biology
Published: September 04, 2024
Revisiting the follicle-stimulation hormone receptor expression and function in human myometrium and adipose tissue.
Journal: Molecular medicine (Cambridge, Mass.)
Published: August 06, 2024
Last Updated: 09/26/2026